Docusate Sodium Oral Liquid
- Product NDC
- 81033-022
- 11-digit product format
- 810330022
- Labeler code
- 81033
- Product ID
- 81033-022_331277b8-8305-d082-e063-6394a90a4dd3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Docusate Sodium Oral Liquid
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Kesin Pharma Corporation
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2025-04-01
- Substance
- DOCUSATE SODIUM
- Active strength
- 100 mg/10mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Docusate Sodium Oral Liquid
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 100 mg/10mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| F05Q2T2JA0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1248119 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 331277b8-8304-d082-e063-6394a90a4dd3 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-022-10 | Docusate Sodium Oral Liquid | 10 mL in 1 CUP, UNIT-DOSE | LIQUID | 10 | 1 | |
| 81033-022-50 | Docusate Sodium Oral Liquid | 100 in 1 CASE | LIQUID | 100 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-022-10 | ML - Milliliter | 81033-022 | 592e48d2-2f24-4f2f-b824-d15fadcaf4be | 1 | 2025-05-14 |
| 81033-022-50 | ML - Milliliter | 81033-022 | 2088ee40-f975-4ca9-b2a3-65a3d1971428 | 1 | 2025-05-14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener Extra Strength | DOCUSATE SODIUM | MEIJER, INC. | e43bd2ed-17c7-4530-af72-81a7ad70069c | 2023-10-12 | Warnings | M007 |
| Stool Softener Plus Stimulant Laxative | DOCUSATE SODIUM AND SENNOSIDES | Care One (Retail Business Services, LLC.) | 9adaec97-43e3-48f2-96c8-c508b693676c | 2023-10-05 | Warnings | M007 |
| Senna Lax | SENNOSIDES 8.6MG | TopCo Associates, LLC | 83aeb90a-ab00-4e26-aa44-5259dce59018 | 2021-04-28 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM | Allegiant Health | 9fbe783e-ddd9-445a-852a-00f4ad754880 | 2021-04-20 | Warnings | M007 |
| Topcare Stool Softener | DOCUSATE SODIUM | TopCo Associates, LLC | 6f4fddda-4129-4087-b0e4-ababc5558484 | 2021-02-19 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM | Allegiant Health | 30c9ff75-cee4-4632-86fd-acfdf5ee85af | 2020-10-27 | Warnings | M007 |
| Stool Softener | MARC GLASSMAN | Marc Glassman, Inc. | 909cd222-d836-416f-aa7d-deb4a0c5a560 | 2020-09-08 | Warnings | M007 |
| Senna Lax | SENNOSIDES 8.6MG | Allegiant Health | 94a9c24a-07c3-4535-b810-b7abc9fc5ad5 | 2019-12-11 | Warnings | M007 |
| Laxative Enteric Coated | BISACODYL 5MG | Marc Glassman, Inc. | ec34fc1e-d122-4fa4-859e-e89e3e12edd5 | 2019-09-18 | Warnings | M007 |
| Womens Laxative | BISACODYL | Marc Glassman, Inc. | aeb3c49b-cbf5-4a47-b19c-e77fbb987a49 | 2019-09-17 | Warnings | M007 |
| Bisacodyl 5mg | BISACODYL 5MG | Allegiant Health | 46a377f5-822b-496f-a73b-66d8f902680a | 2019-03-26 | Warnings | M007 |
| Laxative Enteric Coated | BISACODYL 5MG | Allegiant Health | 51f1c6c0-770c-4426-820b-bc1f42e143fd | 2019-02-07 | Warnings | M007 |
| Senna-Lax | SENNOSIDES | Marc Glassman, Inc. | 7dd97c54-2ba1-4629-87b9-1ba0913fe531 | 2016-12-27 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1248119 | docusate sodium 50 MG in 5 mL Oral Suspension | PSN | 331277b8-8304-d082-e063-6394a90a4dd3 | 1 |
| 1248119 | docusate sodium 10 MG/ML Oral Suspension | SCD | 331277b8-8304-d082-e063-6394a90a4dd3 | 1 |
| 1248119 | docusate sodium 100 MG per 10 ML Oral Suspension | SY | 331277b8-8304-d082-e063-6394a90a4dd3 | 1 |
| 1248119 | docusate sodium 150 MG per 15 ML Oral Suspension | SY | 331277b8-8304-d082-e063-6394a90a4dd3 | 1 |
| 1248119 | docusate sodium 50 MG per 5 ML Oral Suspension | SY | 331277b8-8304-d082-e063-6394a90a4dd3 | 1 |
| 1248119 | DOSS Sodium 10 MG/ML Oral Suspension | SY | 331277b8-8304-d082-e063-6394a90a4dd3 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 81033-022-10 | 81033002210 | 10 mL in 1 CUP, UNIT-DOSE | 10 ml | Historical | |||
| 81033-022-50 | 81033002250 | 100 CUP, UNIT-DOSE in 1 CASE (81033-022-50) / 10 mL in 1 CUP, UNIT-DOSE (81033-022-10) | 2025-04-01 | No | No | Current |